Home›Companies›Biotech & Pharma›Clarametyx Biosciences

Clarametyx Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 19, 2024·Suggest an edit

About Clarametyx Biosciences

Clarametyx Biosciences is a private company based in Columbus, Ohio, incorporated in 2020 in Delaware. It has reported $27,524,145 raised in one offering on Form D since January 2024. Its chief executive is David Richards.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 5, 2024Jan 19, 2024$27,524,145of $33.1M target7$3.9MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Clarametyx Biosciences's Form D filed Jan 19, 2024.

DR
David Richards
Chief Executive Officer
PK
ML
WB
WE
Wayne Embree
Director
CB
LE

Sources

  1. SECClarametyx Biosciences, Inc. filing history